FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs
19th December 2024 Uncategorised 0 FDA reaffirms decision to erase Eli Lilly’s tirzepatide from shortage list, halting future flow of knockoffs
kdunleavy
Thu, 12/19/2024 – 14:50
More: FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs
Source: fierce